Blocknomi
Key Takeaways Boston Scientific shares plummeted approximately 10% following management’s announcement of reduced full-year organic growth projections to 6.5%–8% during the Bernstein Strategic Decisions Conference. Second quarter organic growth expectations…
Related articles
-
Crypto meets Wall Street: MEXC unveils 'RealStocks' with 0-fee U.S. equity trading and real dividends
Cointelegraph Published 01.06.2026 12:40
-
Has Bitcoin Bottomed At $60,000 To Return To $100,000, Or Is This Just The Start Of Another Crash?
NewsBTC Published 01.06.2026 19:00
-
Super Micro Computer (SMCI) Stock Surges 5%+ Following Computex AI Platform Launches
Blocknomi Published 02.06.2026 15:02
-
86% Long Liquidation Wave Exposes Bitcoin’s Breakdown Below $68K as ETF Pressure Builds
Bitcoin.com Published 02.06.2026 15:15
-
Kraken-linked Payward opens tokenized U.S. IPO access to retail investors
Crypto.News Published 03.06.2026 14:41
-
Grayscale Prepares Hyperliquid (HYPE) ETF Launch as Token Surges to Record $75.30
Blocknomi Published 02.06.2026 08:27
-
Bitcoin falls to 2-month low as divergence to equities deepens
Cointelegraph Published 02.06.2026 06:11
-
The Business Owner’s Guide to Vertical Integration with Bitcoin
Bitcoin Magazine Published 01.06.2026 17:20